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Abstract
Cell-mediated reduction of tetrazolium salts, including MTT, XTT, MTS, NBT, NTV, INT, in the presence or absence of
intermediate electron carriers is used as a convenient test for animal or bacterial cell viability. Bioreduction of tetrazolium is
considered an alternative to a clonogenic assay and a thymidine incorporation assay. However, correlation between
clonogenic potential and capacity to reduce tetrazolium has not been demonstrated convincingly. Moreover, despite a wide
use of tetrazolium viability assays, the mechanism and subcellular localisation of reducing systems or species in viable intact
cells have not been fully elucidated. We report evidence indicating that a tetrazolium salt CTC can be reduced in the presence
as well as in the absence of an electron carrier by viable HepG2 human hepatoma cells. CTC-formazan is formed within or at
the outer surface of plasma membranes. We hypothesise that in the presence of an electron carrier the electron donors active
in the reduction of CTC are located in the intracellular compartment, as well as in plasma membranes. However, in the
absence of an electron carrier, the reduction occurs primarily via a plasma membrane-associated enzymatic system or
species. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cell-mediated reduction of tetrazolium salts leads
to corresponding formazans. These reactions are
widely used as indicators of cell viability [1^4], meta-
bolic activity [5^7], oxidative reactions (generation of
oxidative species) [8,9]; they are also used for detec-
tion of reductases in cell and tissue preparations [10^
15] and in cytokine assays [16]. Automated ap-
proaches (microculture tetrazolium assays, MTAs),
aimed at determining proliferation and survival of
cells and screening large numbers of drugs have
been designed [17].
Reduction of tetrazolium salts including MTT,
MTS, XTT, NBT, INT and NTV is regarded as a
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Abbreviations: CTC, 5-cyano-2,3-ditolyl tetrazolium chloride;
DMEM, Dulbecco’s modi¢ed minimal essential medium; INT, 2-
(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chlor-
ide; MB, 8-dimethylamino 2,3-benzophenoxazine (Meldola’s
Blue); MPMS, 1-methoxy phenazine methosulphate; MTS, 5-
(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulpho-
phenyl) tetrazolium, inner salt ; MTT, 3-(4,5-dimethylthiazol-2-
yl)-2,5 diphenyltetrazolium bromide; NBT, 3,3P-(3,3P-dime-
thoxy-4,4P-biphenylene)-bis [2-(4-nitrophenyl-5-phenyl)-2H-tetra-
zolium chloride; NTV, nitro-tetrazolium violet; PI, propidium
iodide; PMS, phenazine methosulphate; XTT, sodium 3P-[1-
[(phenylamino) carbonyl]-3,4-tetrazolium]bis(4-methoxy-6-nitro)
benzensulphonic acid hydrate
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convenient test for cell viability and an alternative to
a clonogenic assay and a thymidine incorporation
assay [4]. The advantage is rapidity, low cost and
simplicity. However, correlation between clonogenic
potential and capacity to reduce tetrazolium has not
been demonstrated convincingly [4,7]. Moreover, de-
spite a wide use of tetrazolium viability assays, the
mechanism of cell-mediated reduction has not been
fully elucidated [4,6,18]. Understanding this mecha-
nism is required for interpretation of MTAs.
Two di¡erent mechanisms may operate in reduc-
tion of membrane permeable and impermeable tetra-
zolium derivatives. MTT, the derivative which has
been in use since the early work in this area probably
penetrates through plasma membranes and is re-
duced intracellularly, in mitochondria [3,19], endo-
plasmic reticulum [5] and cytosol [5]. Other currently
used derivatives, such as XTT, MTS are more hydro-
philic than MTT due to the sulphonate groups on
the former. They may not be capable of crossing
plasma membranes. Thus one may expect that such
hydrophilic derivatives are reduced in bulk medium
or at the cell surface [3,4,13]. In the case of extra-
cellular tetrazolium salts, several interesting questions
arise: what is the reducing species and system re-
sponsible for extracellular reduction? Does this reac-
tion correlate with cell viability and incorporation of
thymidine? Does reduction of extracellular tetrazo-
lium salts a¡ect plasma membrane integrity? The
goal of the research reported here was to establish
the subcellular localisation of a system responsible
for reduction of a tetrazolium salt, CTC, by intact
HepG2 human hepatoma cells in vitro.
Reduction of MTT, NBT, INT, NTV and CTC
lead to formazans precipitating out of water solu-
tions. Investigations of the sites of accumulation of
formazan may assist in establishing the subcellular
localisation of reducing systems. CTC seems partic-
ularly useful in this respect since CTC-formazan is
£uorescent. Thus, the precise detection of small
amounts of CTC-formazan is easier than detection
of non-£uorescent, colour precipitates. The best sen-
sitivity and resolution of detection of CTC-formazan
in cultures of viable cells is o¡ered by £uorescence
confocal microscopy [20]. We used this method to
follow the process of formation of CTC-formazan
by HepG2 cells in vitro in order to establish the
subcellular localisation of the site(s) of reduction of
CTC.
Cell-mediated reduction of XTT, MTS and CTC
(but not MTT) was reported to occur in the presence
of intermediate electron carriers PMS, MPMS or
MB [3,5,7,10,13,14,21]. In most cases studied, an
electron carrier was necessary for reduction to occur.
There were exceptions, however, where formation of
formazan was detected in the absence of an inter-
mediate electron carrier [3,5,6,18,19]. Thus, more
questions arise as to the role these carriers play in
reduction of extracellular tetrazolium salts by viable
cells. Does the carrier move electrons between the
donors located in cell interior and the extracellular
tetrazolium, or between cell surface and extracellular
tetrazolium as well? Do the carrier and tetrazolium
a¡ect cell metabolism, plasma membrane integrity
and thus in£uence the parameter which is measured?
We report evidence indicating that CTC can be re-
duced in the absence of an intermediate electron car-
rier while the integrity of plasma membranes is not
compromised. Under such conditions, it can be dem-
onstrated that the systems reducing tetrazolium are
associated with plasma membranes as well as with an
intracellular compartment.
2. Materials and methods
2.1. Reagents
CTC (5-cyano-2,3-ditolyl tetrazolium chloride)
was purchased from Polysciences; MB (8-dimethyl-
amino 2,3-benzophenoxazine, Meldola’s Blue) and
digitonin were obtained from Sigma. Solutions of
CTC, MB and digitonin were made immediately pri-
or to experiments.
2.2. Cell cultures
HepG2 human hepatoma cells were cultured on
20-mm-diameter, 0.17-mm-thick coverslips placed in
Petri dishes. DMEM (Sigma) supplemented with
10% foetal bovine serum (Gibco) and antibiotics
was used. Monolayers (1 day after seeding) were
used in all experiments. Cell density was approxi-
mately 1.5U105/ml of medium (190 cells/mm2).
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2.3. Plasma membrane integrity assay
Integrity of plasma membranes was monitored us-
ing a propidium iodide (PI) exclusion test [22]. PI
was added to cell cultures to a ¢nal concentration
of 50 Wg/ml. Red £uorescence of nuclei of damaged
cells was detected using confocal microscopy. A cul-
ture of cells treated with digitonin (0.1 mM) served
as a positive control.
2.4. Confocal microscopy
Fluorescence of PI and CTC-formazan was de-
tected using laser scanning confocal microscopy
(CLSM). We used a Bio-Rad MRC1024 system
equipped with a Nikon Diaphot 300 microscope,
60U PlanApo oil immersion objective lens, 15 mW
argon^krypton laser (ALC), three £uorescence detec-
tion channels and a three-colour transmitted non-
confocal light detector. The 488 line and a 30% neu-
tral density ¢lter was used for simultaneous excita-
tion of PI and CTC-formazan. A 565LP dichroic
mirror was used for specimen epi-illumination. Fluo-
rescence of PI in cell nuclei was collected in the re-
gion of 585^640 nm, while CTC-formazan in the
region 580 up to approximately 750 nm. Coverslips
with cell cultures were withdrawn from Petri dishes
and mounted in a round steel holder using silicone
grease. The holder was ¢tted in the pre-warmed mi-
croscope stage microincubator (Life Sciences Re-
search, Cambridge, UK). The standard culture me-
dium was replaced with DMEM without phenol red
and bicarbonate, with pH adjusted to 7.4. The sam-
ple contained 250 ml of culture medium in equili-
brium with air. Incubations with CTC (5 mM)
were conducted at 37‡C in air. During incubation
transmission and £uorescence images of cells were
collected in 1.5- or 2.5-min intervals. 512U512 pixels,
256 grey level images were collected using Laser-
Sharp 2.1T software (Bio-Rad).
2.5. Spectroscopic measurements
CTC (0.5 mM) was dissolved in PBS. A suspen-
sion of crystals of CTC-formazan in PBS was ob-
tained by reduction of CTC (0.5 mM) by ascorbate
(2.5 mM). Absorption spectra (200^800 nm) of CTC
and CTC-formazan were collected using an HP 8542
UV/VIS spectrophotometer. Fluorescence emission
and excitation spectra of CTC and CTC-formazan
were measured using Perkin^Elmer LS50 spectro-
£uorometer.
2.6. Data analysis
CTC-formazan was detectable by confocal micros-
copy due to its red £uorescence. The growth of
CTC-formazan crystals was observed by registering
time sequences of images of the same areas of the cell
culture. Sequences were collected and analysed using
automated routines of the TimeCourse software
(Bio-Rad). For analysis, 10^15 regions embracing
cell membranes, cell interiors or surrounding medium
were selected in each experiment. The mean inten-
sities of red £uorescence in each region were plotted
against time.
Detection of cell edges and thus the position of
plasma membranes was based on transmitted light
images. The position of crystals of formazan relative
to plasma membranes was determined by overlaying
the confocal images of red £uorescence over non-
confocal transmitted light images taken through the
cell centre. It follows that, depending on the shape of
individual cells and position of a confocal slice, the
edges of cells on confocal slices overlapped or fell
just inside the edges on transmitted light images.
Fig. 1. Absorbance of CTC (0.4 mM) and CTC-formazan crys-
tals formed in air-equilibrated PBS, at room temperature, fol-
lowing addition of ascorbate (1 mM).
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3. Results
3.1. Spectroscopic properties of CTC
CTC readily dissolves in water. The solution ab-
sorbs in the UV region, up to 400 nm, with two
maxima at approximately 216 and 300 nm (Fig. 1).
Fig. 2. Excitation (em. 630 nm) and emission (exc. 488 nm)
spectra of CTC (0.5 mM, dissolved in PBS) and CTC-formazan
(a suspension of crystals).
C
Fig. 3. Formation of crystals of CTC-formazan in a monolayer
culture of intact HepG2 cells, in the presence of an electron
carrier. Scale bar: 10 Wm. Left column: transmitted light (488
nm) images of HepG2 cells. Images were collected at times indi-
cated following the addition of CTC. As time progresses, the
cytoplasm absorbs more blue light due to penetration of MB
into cells. Blebs forming from plasma membranes at the end of
the incubation period are indicated (bl). Right column: confo-
cal images of red £uorescence in HepG2 cells shown in the left
column. Thickness of the optical sections 1.2 Wm. Small crystals
of CTC-formazan (fc) are forming near cell surface. No red £u-
orescence of PI can be detected in cell nuclei indicating that the
integrity of plasma membranes was not compromised. Small
red dots in cytoplasm of the image at time 0 are due to auto-
£uorescence. Bottom: intensities of red £uorescence in culture
medium surrounding the cells, in plasma membranes and in cy-
toplasm. Intensities of red £uorescence were measured along
the white lines, starting with a dot, which were marked in con-
focal images (right column). The position of cell plasma mem-
branes is marked with arrows. Red £uorescence of CTC-forma-
zan is concentrated at the plasma membranes, no formazan is
detected in medium or cell interior.
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Following addition of ascorbate the CTC solution
gradually changed colour to orange due to formation
of CTC-formazan. The CTC-formazan precipitated
out of solution within 5 min of incubation. The ab-
sorption curve of a suspension of CTC-formazan
crystals has a band in the UV region extending up
to 400 nm (Fig. 1) (one has to note, however, that
the absorption curve of CTC-formazan refers to a
suspension of particles rather than a solution and,
as such, may be a combined e¡ect of light absorption
and dispersion). When excited with blue light (488
nm) CTC exhibited no £uorescence while CTC-for-
mazan emitted light in the broad region extending
from 500 to 750 nm, with a maximum at approxi-
mately 630 nm (Fig. 2). Excitation spectrum of CTC-
formazan has a narrow peak at 318 nm and a broad
region extending from 360 to 550 nm (Fig. 2).
3.2. Reduction of CTC by HepG2 cells in the presence
of an electron carrier
Cell-mediated reduction of CTC was investigated
in monolayer cultures of HepG2 cells. CTC, an elec-
tron carrier Meldola’s Blue, and a plasma membrane
integrity indicator PI, were added to culture medium.
Within a few minutes of addition of CTC, crystals of
CTC-formazan were formed in the regions of cell
plasma membranes (Fig. 3). These crystals measured
up to 2 Wm in length and were always adjacent to
plasma membranes of HepG2 cells. The whole se-
quence of images that were collected demonstrates
that the crystals were formed exclusively at cell sur-
faces. No crystals were formed in cell interior or in
the bulk medium. The growth of the intensity of
£uorescence of CTC-formazan at cell surfaces is
shown in Fig. 4. An example of the intensities of
£uorescence of CTC-formazan measured in culture
medium surrounding the cells, in the regions of plas-
ma membranes and in the cytoplasm is shown in Fig.
3, bottom. Transmitted light images indicate that
MB was entering cells (Fig. 3). During the incubation
with MB and CTC plasma membrane integrity was
not compromised as demonstrated by the absence of
PI £uorescence from cell nuclei (Fig. 3). However,
formation of membrane blebs [23] was detected
(Fig. 3). This phenomenon indicated that damage
to plasma membranes or cytoskeleton occurred,
although it was not yet manifested by the increased
plasma membrane permeability.
No reduction of CTC was detected in the absence
of cells indicating that the medium alone did not
have a capacity to reduce CTC.
3.3. Reduction of CTC in the absence of an electron
carrier
HepG2 cells are capable of reducing CTC to CTC-
formazan in the absence of an electron carrier. In
cultures without MB, CTC-formazan was still grad-
ually formed at cell surfaces over a period of 1 h
(Figs. 5 and 6). The size of crystals was below the
resolution of an optical microscope (i.e. below ap-
proximately 250 nm). The intensities of red £uores-
cence in plasma membranes and in the intracellular
compartment are shown in Fig. 5, bottom. These
data demonstrate that the presence of MB was not
a prerequisite for reduction of CTC by HepG2 cells.
Both in the presence and in the absence of MB the
crystals of CTC-formazan were formed in the regions
of plasma membranes. The integrity of plasma mem-
branes was not compromised (Fig. 6). The rate of
reaction was approximately 13 times slower in the
absence than in the presence of MB.
Fig. 4. Kinetics of formation of CTC-formazan in the presence
of MB (left axis) and a proportion of cells with intact plasma
membranes (right axis). PM, intensity of red £uorescence meas-
ured in the regions of cell plasma membranes; CTRL, red £uo-
rescence of plasma membranes measured in a parallel control
experiment, in the absence of CTC.
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4. Discussion
The experiments described above were carried out
in order to establish the subcellular localisation of
the site(s) of reduction of CTC. We will discuss ex-
perimental evidence supporting the view that CTC is
reduced to formazan within or on surfaces of plasma
membranes of intact cells, by enzyme system(s) resid-
ing in cell interior as well as associated with plasma
membranes.
4.1. Penetration of CTC through plasma membranes
The extracellular or intracellular reduction of tet-
razolium and subsequent deposition of formazan
may depend on the ability of tetrazolium to cross
plasma membranes. To our knowledge, penetration
of tetrazolium salts into intact viable cells has not
been measured directly. In the case of CTC, reports
exist referring to both intracellular formation of for-
mazan in bacteria detected by optical microscopy
[24,25] and extracellular deposition of CTC-forma-
zan formed on plasma membranes of Ehrlich ascites
cells [13,14]. The presence of a stable positive charge
in the tetrazolium salt molecule [26] may be expected
to limit the ability of tetrazolium salts to penetrate
freely through intact plasma membranes of viable
cells. In our experiments, the integrity of plasma
membranes of HepG2 cells was carefully monitored
and shown not to be compromised during incubation
with CTC and MB. Under these conditions, CTC-
formazan was detected entirely in the regions of plas-
ma membranes. In a series of control experiments,
6
Fig. 5. Formation of crystals of CTC-formazan in a monolayer
culture of HepG2 cells, in the absence of an electron carrier.
Scale bar: 10 Wm. Left column: transmitted light (488 nm) im-
ages of HepG2 cells Right column: confocal images of red £uo-
rescence in HepG2 cells shown in the left column. Thickness of
optical sections, 1.2 Wm. CTC-formazan (fc) is forming near cell
surface. No red £uorescence of PI can be detected in cell nuclei
indicating that the integrity of plasma membranes was not com-
promised. Bottom: intensities of red £uorescence in plasma
membranes and in the cytoplasm. Intensities of red £uorescence
were measured along the white lines, starting with a dot, which
were marked in confocal images (right column). The position of
cell membranes is marked with arrows. Red £uorescence of
CTC-formazan is concentrated at the plasma membranes, no
formazan is detected in cell interior.
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plasma membranes were rendered permeable by
treatment with digitonin. Under these conditions,
we detected formation of crystals of CTC-formazan
intracellularly (data not shown). This observation is
consistent with the observation of Stellmach [13] who
reported an increased rate of reduction of CTC by
Ehrlich ascites cells challenged with digitonin. Thus,
it seems possible that during incubations with intact
HepG2 cells reported here CTC remained in the ex-
tracellular space.
4.2. The site(s) of CTC reduction
Following reduction of CTC, crystals of CTC-for-
mazan precipitate out of solution. Thus, in cultures
of HepG2 cells the crystals are probably formed at
the sites of reduction. Analysis of the confocal im-
ages recorded during incubations of intact cells with
CTC, in the presence and in the absence of MB,
indicate that formation of CTC crystals took place
at or near plasma membranes. Therefore we con-
clude that the process of reduction of CTC occurs
at the cell surface or within cellular plasma mem-
branes.
Deposition of CTC-formazan might result from
exocytosis of crystals formed in cell interior. Exocy-
tosis of formazan crystals by neuronal cells was re-
ported [6]. This mechanism, however, was not in-
volved in deposition of CTC-crystals on the surface
of HepG2 cells. The time sequence images we col-
lected clearly demonstrate that in HepG2 cell cul-
tures the crystals of CTC-formazan were neither
formed intracellularly nor were they transported
across cytoplasm.
4.3. The role of an intermediate electron carrier
In the majority of published reports, reduction of
tetrazolium was carried out in the presence of inter-
mediate electron carriers PMS, MPMS and MB. The
most e¡ective electron carrier in CTC reduction was
MB [14]. MB was also e¡ective in the system we
studied. However, in HepG2 hepatoma cells, unlike
in Ehrlich ascites cells [13,14], MB was not required
for reduction of extracellular CTC to formazan ac-
cumulating in plasma membranes. This observation
indicates that one of the putative reducing systems
was located in plasma membranes. This system did
not require an exogenous electron carrier.
Formation of CTC-formazan was faster in the
presence of Meldola’s Blue than without this electron
carrier. MB is known to be capable of undergoing
reversible reduction and oxidation [27]. MB may also
cross intact plasma membranes [21,27]. Analysis of
transmitted light images suggests that MB indeed
penetrated into cells. There is no direct evidence
demonstrating that MB in reduced form can di¡use
out of cells. However, one may put forward a hy-
pothesis that MB carried electrons between intracel-
lular donors and extracellular CTC. In this case, the
presence of a membrane permeable electron carrier
would enable electron transfer from intracellular
electron donors onto the extracellular tetrazolium.
This mechanism would constitute an example of for-
mazan produced at a distance from reducing en-
zyme(s).
4.4. The reducing system/species
Depending on the presence or absence of an elec-
tron carrier CTC may be reduced by di¡erent reduc-
ing systems.
In the presence of MB, electrons may be trans-
Fig. 6. Kinetics of formation of CTC-formazan in the absence
of an electron carrier (left axis) and a proportion of cells with
intact plasma membranes (right axis). PM, intensity of red £uo-
rescence in the regions of plasma membranes; CTRL, red £uo-
rescence measured in a parallel control experiment, in the ab-
sence of CTC.
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ported by an electron carrier from mitochondria or
cytosol to the extracellular tetrazolium. Mitochon-
drial [3,19,28] as well as cytosolic [7,19] and ER-as-
sociated [5,19] oxidoreductases were shown to be in-
volved in the reduction of MTT. It is possible that
these enzymes may also be involved in the reduction
of CTC via MB as a membrane permeable electron
carrier.
In the absence of MB, the reduction may be per-
formed by a plasma membrane reducing enzyme sys-
tem or a short-lived reducing species. The enzyme
systems capable of transferring electrons directly
onto CTC may involve plasma membrane oxidore-
ductases, including oxidoreductase NAD(P)H: ferri-
cyanide [29^32] and NAD(P)H: O2 [33,34]. These
enzymes are present in ¢broblasts, adipocytes [29]
and hepatocytes [34,35]. Plasma membranes of intact
HepG2 cells have a capacity to reduce another ex-
tracellular acceptor of electrons ^ a nitroxide free
radical Cat1 [36]. Further studies are needed to es-
tablish if CTC and other tetrazolium salts can serve
as arti¢cial acceptors of electrons for plasma mem-
brane oxidoreductases in hepatocytes.
A possibility exists that CTC was reduced by
superoxide radical [37] produced by HepG2 cells.
The radical which is generated in mitochondria and
elsewhere in the cell cannot di¡use over distances
long enough to reach extracellular CTC. However,
NADH oxidase activity was detected in plasma
membranes of hepatocytes [35] and hepatoma cells
[38]. Therefore, one may also hypothesise that CTC
was reduced by oxygen radicals generated within
plasma membranes.
5. Conclusions
Based on the data presented in this report we con-
clude that: (1) CTC may not penetrate through in-
tact plasma membranes of HepG2 cells; (2) it is re-
duced to CTC-formazan within or on the surface of
plasma membranes; (3) the reducing systems or spe-
cies capable of reduction of CTC to formazan appear
to be located both intracellularly and in plasma
membranes; (4) in the presence of a membrane per-
meable intermediate electron carrier reducing systems
in both compartments may be involved; and (5) in
the absence of an electron carrier, CTC is reduced
exclusively by an as yet unidenti¢ed plasma mem-
brane reductase.
Acknowledgements
We thank Prof. P.A. Riley of the University Col-
lege London for interesting discussions, Mrs. Bar-
bara Czuba-Pelech, Eng., for skilful technical assis-
tance and Mr. B. Rajwa, MSc, for help with image
processing. The ¢nancial assistance of the Polish
State Committee for Science (KBN 2224/4/91 and
6P04A 070 15), Foundation for Polish^German Co-
operation in Warsaw (FWPN 994/94) is gratefully
acknowledged.
References
[1] T. Satoh, H. Isobe, K. Ayukawa, H. Sakai, H. Nawata, The
e¡ects of pravastatin, an HMG-CoA reductase inhibitor, on
cell viability and DNA production of rat hepatocytes, Life
Sci. 59 (1996) 1103^1108.
[2] M.S. Shearman, Cellular MTT reduction distinguishes the
mechanism of action of beta-amyloid from that of tachyki-
nin receptor peptides, Neuropeptides 30 (1996) 125^132.
[3] M.S. Shearman, S.R. Hawtin, V.J. Tailor, The intracellular
component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) reduction is speci¢cally in-
hibited by beta-amyloid peptides, J. Neurochem. 65 (1995)
218^227.
[4] N.J. Marshall, C.J. Goodwin, S.J. Holt, A critical assess-
ment of the use of microculture tetrazolium assays to meas-
ure cell growth and function, Growth Regul. 5 (1995) 69^84.
[5] C.J. Goodwin, S.J. Holt, P.A. Riley, S. Downes, N.J. Mar-
shall, Growth hormone-responsive DT-diaphorase-mediated
bioreduction of tetrazolium salts, Biochem. Biophys. Res.
Commun. 226 (1996) 935^941.
[6] Y. Liu, D. Schubert, Cytotoxic amyloid peptides inhibit cel-
lular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction by enhancing MTT formazan
exocytosis, J. Neurochem. 69 (1997) 2285^2293.
[7] H.J. Prohaska, A.B. Santamaria, Quinone reductase from
cells cultured in microliter wells : a screening assay for anti-
carcinogenic enzyme inducers, Anal. Biochem. 169 (1988)
328^336.
[8] L. Carpenter Deyo, D.J. Reed, Involvement of calcium and
iron in Quin 2 toxicity to isolated hepatocytes, J. Pharmacol.
Exp. Ther. 258 (1991) 747^752.
[9] P. Gorog, I.B. Kovacs, Lipid peroxidation by activated pla-
telets : a possible link between thrombosis and atherogenesis,
Atherosclerosis 115 (1995) 121^128.
[10] D.A. Benau, W.G. Schumacher, E.J. McGuire, S. Fitzpa-
BBAMCR 14499 30-7-99
T. Bernas, J. Dobrucki / Biochimica et Biophysica Acta 1451 (1999) 73^8180
trick McElligott, B.T. Storey, S. Roth, Light microscopic
localization of glycosyltransferase activities in cells and tis-
sues, J. Histochem. Cytochem. 38 (1990) 23^30.
[11] A. Kooij, W.M. Frederiks, R. Gossrau, C.J. Van Noorden,
Localization of xanthine oxidoreductase activity using the
tissue protectant polyvinyl alcohol and ¢nal electron accept-
or Tetranitro BT, J. Histochem. Cytochem. 39 (1990) 87^93.
[12] H. Faber Zuschratter, T. Seidenbecher, K. Reymann, G.
Wolf, Ultrastructural distribution of NADPH-diaphorase
in the normal hippocampus and after long-term potentia-
tion, J. Neural Transm. Gen. Sect. 103 (1996) 807^817.
[13] J. Stellmach, Fluorescent redox dyes. 1. Production of £uo-
rescent formazan by unstimulated and phorbol ester- or dig-
itonin-stimulated Erlich ascites tumor cells, Histochemistry
80 (1984) 137^143.
[14] J. Stellmach, E. Severin, A £uorescent redox dye. In£uence
of several substrates and electron carriers on the tetrazolium
salt-formazan reaction of Ehrlich ascites tumour cells, His-
tochem. J. 19 (1987) 21^26.
[15] C. van Noorden, F. Dolbeare, J. Aten, Flow cyto£uorimetric
analysis of enzyme reactions based on quenching of £uores-
cence by ¢nal reaction product: detection of glucose-6-phos-
phate dehydrogenase de¢ciency in human erythrocytes,
J. Histochem. Cytochem. 37 (1989) 1313^1318.
[16] A.R. Mire-Sluis, R. Thorpe, Laboratory protocols for quan-
titation of cytokines by bioassay using cytokine responsive
cell lines, J. Immunol. Methods 211 (1998) 199^210.
[17] M.C. Alley, D.A. Scudiero, A.E. Monks, Feasibility of drug
screening with panels of human tumor cell lines using a
microculture tetrazolium assay, Cancer Res. 48 (1988) 589^
601.
[18] W.S. Thayer, Superoxide-dependent and superoxide-inde-
pendent pathways for reduction of nitroblue tetrazolium in
isolated rat cardiac myocytes, Arch. Biochem. Biophys. 276
(1990) 139^145.
[19] M.V. Berridge, A.S. Tan, Characterization of the cellular
reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT): subcellular localization, substrate de-
pendence, and involvement of mitochondrial electron trans-
port in MTT reduction, Arch. Biochem. Biophys. 303 (1993)
474^482.
[20] J.B. Pawley (Ed.), Handbook of Biological Confocal Micros-
copy, Plenum Press, New York, 1995, pp. 167^173.
[21] C. van Noorden, J. Tas, The role of exogenous electron
carriers in NAD(P)-dependent dehydrogenase cytochemistry
studied in vitro and with model system of polyacrylamide
¢lms, J. Histochem. Cytochem. 30 (1982) 12^20.
[22] N.J. London, H. Contractor, S.P. Lake, G.C. Aucott, P.R.
Bell, R.F. James, A micro£uorometric viability assay for
isolated human and rat islets of Langerhans, Diabetes Res.
12 (1989) 141^149.
[23] B. Herman, G.J. Gores, A.L. Nieminen, T. Kawanishi, A.
Harman, J.J. Lemasters, Calcium and pH in anoxic and
toxic injury, Crit. Rev. Toxicol. 21 (1990) 127^148.
[24] G.G. Rodriguez, D. Phipps, K. Ishiguro, H.F. Ridgway, Use
of a £uorescent redox probe for direct visualization of ac-
tively respiring bacteria, Appl. Environ. Microbiol. 58 (1992)
1801^1808.
[25] G. Schaule, H.C. Flemming, H.F. Ridgway, Use of 5-cyano-
2,3-ditolyl tetrazolium chloride for quantifying planktonic
and sessile respiring bacteria in drinking water, Appl. Envi-
ron. Microbiol. 59 (1993) 3850^3857.
[26] F.P. Altman, Tetrazolium salts and formazans, Prog. Histo-
chem. Cytochem. 9 (1976) 1^56.
[27] P. Kugler, K.H. Wrobel, Meldola Blue: a new electron car-
rier for the histochemical demonstration of dehydrogenases
(SDH, LDH, G-6-PDH), Histochemistry 59 (1978) 97^109.
[28] D.S. Heo, J.G. Park, K. Hata, R. Day, R.B. Herberman,
T.L. Whiteside, Evaluation of tetrazolium-based semiauto-
matic colorimetric assay for measurement of human antitu-
mor cytotoxicity, Cancer Res. 50 (1990) 3681^3690.
[29] F.L. Crane, I.L. Sun, M.G. Clark, C. Grebing, H. Low,
Transplasma-membrane redox systems in growth and devel-
opment, Biochim. Biophys. Acta 811 (1985) 233^264.
[30] D.J. Morre, A.O. Brightman, NADH oxidase of plasma
membranes, J. Bioenerg. Biomembr. 23 (1991) 469^489.
[31] B. Meier, A.R. Cross, J.T. Hancock, F.J. Kaup, O.T. Jones,
Identi¢cation of a superoxide-generating NADPH oxidase
system in human ¢broblasts, Biochem. J. 275 (1991) 241^
245.
[32] S.P. Mukherjee, W.S. Lynn, Reduced nicothiamide adenine
dinucleotide phosphate oxidase and its activation by insulin,
Arch. Biochem. Biophys. 184 (1977) 69^76.
[33] Y. Mizukami, F. Matsubara, S. Matsukawa, Cytochemical
localization of peroxidase and hydrogen-peroxide-producing
NAD(P)H-oxidase in thyroid follicular cells of propylthiour-
acil-treated rats, Histochemistry 82 (3) (1985) 263^268.
[34] Y. Mizukami, F. Matsubara, S. Matsukawa, R. Izumi, Cyto-
chemical localization of glutaraldehyde-resistant NAD(P)H-
oxidase in rat hepatocytes, Histochemistry 79 (2) (1983) 259^
267.
[35] I.L. Sun, P. Navas, F.L. Crane, D.J. Morre, H. Low,
NADH diferric transferrin reductase in liver plasma mem-
brane, J. Biol. Chem. 262 (1987) 15915^15921.
[36] T. Bernas, J. Dobrucki, Extracellular reduction of Cat1 free
radical by transformed human hepatocytes, Biosci. Rep. 18
(6) (1999) 341^350.
[37] B. Halliwell, J.M.C. Gutteridge (Eds.), Free Radicals in Bi-
ology and Medicine, Oxford University Press, Oxford, 1985.
[38] M. Bruno, A.O. Brightman, J. Lawrence, D. Werderitsh,
D.M. Morre, D.J. Morre, Stimulation of NADH oxidase
activity from rat liver plasma membranes by growth factors
and hormones is decreased or absent with hepatoma plasma
membranes, Biochem. J. 284 (1992) 625^628.
BBAMCR 14499 30-7-99
T. Bernas, J. Dobrucki / Biochimica et Biophysica Acta 1451 (1999) 73^81 81
